CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...